Acute liver injury after SARS-CoV-2 vaccination and luspatercept administration in a patient with β-thalassemia.

Authors :: Leoni S
Bou-Fakhredin R
Granata F
Cassinerio E
Maggioni M
Fracanzani AL
Cappellini MD
Motta I
Source :: Annals of hematology [Ann Hematol] 2024 Mar; Vol. 103 (3), pp. 1025-1026. Date of Electronic Publication: 2024 Jan 03.
Publication Year :: 2024

Subjects :: Humans
Recombinant Fusion Proteins therapeutic use
Vaccination
Activin Receptors, Type II therapeutic use
beta-Thalassemia complications
beta-Thalassemia drug therapy
COVID-19 prevention & control
COVID-19 Vaccines adverse effects
Immunoglobulin Fc Fragments therapeutic use

Full Text Access

Tools